Tag: FDA

FDA grants full approval to Moderna Covid vaccine for kids but limits eligibility

Moderna, a leading pharmaceutical company, has achieved a significant milestone in the fight against Covid-19 by obtaining full

STAT+: Fed-up and demoralized, FDA staff are leaving.

The recent Chesapeake Baysox game on July 4th was a festive event filled with entertainment and excitement. Between

Healthcare Robotics Pioneer Mendaera Announces FDA Clearance

Healthcare robotics pioneer Mendaera has recently received FDA 510(k) clearance for its groundbreaking handheld robotic system, Focalist. This

America’s Frontline Doctors Petitions FDA to Make HCQ and Ivermectin Over-the-Counter |

Credit: BMF/Zoll Removing Hurdles to Essential Medications On June 26, 2025, Dr. Simone Gold alongside America’s Frontline Doctors

Smoking Cessation Aid Cytisinicline Could Soon Get FDA Approval

Achieve Life Sciences has recently submitted a new drug application to the FDA for cytisinicline, a non-nicotine smoking

FDA Issues Warning Over Dangerous ‘Gas Station Heroin’ Substance : ScienceAlert

The US Food and Drug Administration (FDA) has issued an urgent warning about tianeptine – a substance marketed

STAT+: Radical transparency at the FDA, and a pivotal moment for vaccines

You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and policy of health

RFK Jr., FDA eye psychedelics for mental health treatment

Olivia Goldhill, a dedicated advocate for reproductive health, mental health, and psychedelics, has been closely following the recent

For HIV/AIDS, FDA approves next best thing to a vaccine

The Food and Drug Administration has recently approved a groundbreaking new drug that could revolutionize HIV prevention. This

FDA approves Moderna RSV vaccine use for people aged 18 to 59

The Food and Drug Administration recently granted an extension to Moderna's RSV vaccine, allowing it to be used

Merck’s RSV treatment for infants is approved by FDA

A groundbreaking development in the fight against respiratory syncytial virus (RSV) was announced on Monday with the approval

FDA hints relaxed rules are coming for rare disease gene therapy

The Trump administration's impact on gene therapy was a topic of discussion at a recent FDA "Cell and